HutchMed (NASDAQ: HCM, HKG: 0013) today announced a significant change in leadership with the long-serving Chairman Simon To preparing to step down from his executive role. After a tenure of 23 years with the company, To will transition to a non-executive board director role while also serving as a strategic advisor.
Dr. Dan Eldar, who has been a non-executive director at HutchMed since 2016, will be taking over the reins as chairman. Eldar brings with him over 30 years of experience as a senior executive with a proven track record of leading global operations across various sectors, including telecommunications, water, biotech, and healthcare. He currently holds the position of executive director at Hutchison Water Israel EPC Ltd and is associated with the CK Hutchison Group. Dr. Eldar holds an MA and PhD in government from Harvard University, complemented by a BA and MA in political science from the Hebrew University of Jerusalem.- Flcube.com
